Researchers suggest that a heart health evaluation should be made mandatory for women before they are prescribed estrogen replacement because research has shown that such hormone therapy could accentuate certain specific pre-existing heart disease risk factors.
MaryFran Sowers, lead researcher and professor of epidemiology at the University of Michigan School of Public Health, said that the research has also shown that in women without existing atherosclerosis, hormone therapy use included some positive effects on lipids but also some negative effects related to heart health.
Hot Flash
The frequency of the hot flash can be from 1 to 2 two hot flashes a week to 10 or greater in a day. The silver lining is that it usually decreases over time.
Advertisement
She said that the study came about in trying to explain what's behind the so-called timing hypothesis.
The timing hypothesis suggests that if a woman implements a hormone therapy program within six years of her final menstrual period, this narrow window is enough to deter heart disease from developing with the onset of menopause.
![Lobular Breast Cancer Risk Upped Four Times By Combined HRT]( "Lobular Breast Cancer Risk Upped Four Times By Combined HRT")
Researchers reveal that combined estrogen/progestin hormone-replacement therapy (HRT) leads to a fourfold increased risk of developing lobular breast cancer.
Sowers, however, said that the findings suggest that explanation isn't quite so simple. Even within the six-year window, there were negative aspects related to heart disease.
Sowers said that while the positive outcomes on HDL and LDL cholesterol levels were observed, researchers also saw negative outcomes in terms of the inflammation process-which can be related to heart disease.
She said that the research shows it's critical for women considering hormone therapy to discuss their heart health with their doctor.
"If the woman walks into the doctor's office with a certain degree of (heart disease) burden already, then she and her health care provider may decide that hormone therapy adds too much to the burden," Sowers said.
"If she doesn't have that burden, they may decide that hormone therapy is an acceptable burden.
"The woman should say to her health care provider, 'What kind of information do we need to gather in order to make an informed decision about whether or not hormone therapy should be pursued.'
'"I understand there could be some heart disease risk, but that the risk may be based upon where I am now, and can you tell me where that is?'" Sowers said.
Sowers said that heart disease risk could be measured through lipid panels, which are standard, but also by measuring inflammation markers.
She said that the tests for inflammation markers exist but their measurement isn't standard when a woman is considering hormone therapy.
Source: ANI
TAN/L
Lobular Breast Cancer Risk Upped Four Times By Combined HRT
Researchers reveal that combined estrogen/progestin hormone-replacement therapy (HRT) leads to a fourfold increased risk of developing lobular breast cancer.
Advertisement
Sowers, however, said that the findings suggest that explanation isn't quite so simple. Even within the six-year window, there were negative aspects related to heart disease.
Sowers said that while the positive outcomes on HDL and LDL cholesterol levels were observed, researchers also saw negative outcomes in terms of the inflammation process-which can be related to heart disease.
She said that the research shows it's critical for women considering hormone therapy to discuss their heart health with their doctor.
"If the woman walks into the doctor's office with a certain degree of (heart disease) burden already, then she and her health care provider may decide that hormone therapy adds too much to the burden," Sowers said.
"If she doesn't have that burden, they may decide that hormone therapy is an acceptable burden.
"The woman should say to her health care provider, 'What kind of information do we need to gather in order to make an informed decision about whether or not hormone therapy should be pursued.'
'"I understand there could be some heart disease risk, but that the risk may be based upon where I am now, and can you tell me where that is?'" Sowers said.
Sowers said that heart disease risk could be measured through lipid panels, which are standard, but also by measuring inflammation markers.
She said that the tests for inflammation markers exist but their measurement isn't standard when a woman is considering hormone therapy.
Source: ANI
TAN/L
Quantum of heart-attack risk in women determined by age and HRT therapy
A new study has said that the right method of Hormone Replacement Therapy (HRT) taken at the right age can determine a woman's risk of having a heart-attack.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Women Health News
Cardiovascular rehabilitation, which lowers mortality and readmission rates, is underutilized and less effective in women than in men.
Laser speckle wearable gadget helps in the early detection of postpartum hemorrhage, potentially reducing maternal mortality rates.
More than 90% of previously unexplained pregnancy losses or miscarriages were accurately determined by placental testing.
Fetal growth restriction impacts around 60,000 infants annually in Europe and the United States.
For women under 40, trying to conceive, timing intercourse around the fertile period using a urine ovulation test increases the chances of pregnancy.
